MARKET

MRK

MRK

Merck & Co
NYSE
123.61
+2.83
+2.34%
After Hours: 123.50 -0.11 -0.09% 19:40 07/15 EDT
OPEN
124.25
PREV CLOSE
120.78
HIGH
124.90
LOW
122.75
VOLUME
9.05M
TURNOVER
--
52 WEEK HIGH
130.29
52 WEEK LOW
74.18
MARKET CAP
305.29B
P/E (TTM)
34.78
1D
5D
1M
3M
1Y
5Y
1D
Best ETFs to Invest In, According to AI Analyst, 7/15/2026
TipRanks · 5h ago
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer
Benzinga · 7h ago
Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Merck & Company (MRK) and Viking Therapeutics (VKTX)
TipRanks · 12h ago
Merck posts late-stage trial win for frontline Keytruda in endometrial cancer
Seeking Alpha · 13h ago
Merck to present new data from research pipeline for HIV treatment, prevention
TipRanks · 13h ago
Merck's Keytruda Phase 3 Trial Meets Primary Endpoint In Endometrial Cancer
NASDAQ · 13h ago
Merck says Phase 3 KEYNOTE-C93 trial of Keytruda met primary endpoint
TipRanks · 14h ago
Merck's Phase 3 KEYNOTE‑C93 Trial Evaluating KEYTRUDA Met Primary Endpoint Of Progression-Free Survival For Treatment Of Patients With Mismatch Repair Deficient Advanced Or Recurrent Endometrial Cancer
Benzinga · 14h ago
More
About MRK
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Webull offers Merck & Co Inc stock information, including NYSE: MRK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRK stock methods without spending real money on the virtual paper trading platform.